BioNTech SE (BNTX) FCF Payout Ratio (2022)

BioNTech SE (BNTX) reported FCF Payout Ratio of 1.0 for Q4 2022, up 1105.76% sequentially from 0.1 in Q3 2022.

BioNTech SE (BNTX) FCF Payout Ratio (2022) Analysis & Trends

BioNTech SE (BNTX) has 1 years of FCF Payout Ratio data on file, last reported at 1.0 in Q4 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	FCF Cover (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	-
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	0.12
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	BioNTech SE	22.13 Bn	22.13 Bn	668.28 Mn	-

Download Data